Literature DB >> 12668633

A novel role for a nodal-related protein; Xnr3 regulates convergent extension movements via the FGF receptor.

Chika Yokota1, Matt Kofron, Mike Zuck, Douglas W Houston, Harry Isaacs, Makoto Asashima, Chris C Wylie, Janet Heasman.   

Abstract

Convergent extension behaviour is critical for the formation of the vertebrate body axis. In Xenopus, components of the Wnt signaling pathway have been shown to be required for convergent extension movements but the relationship between cell fate and morphogenesis is little understood. We show by loss of function analysis that Xnr3 activates Xbra expression through FGFR1. We show that eFGF activity is not essential in the pathway, and that dishevelled acts downstream of Xnr3 and not in a parallel pathway. We provide evidence for the involvement of the EGF-CFC protein FRL1, and suggest that the pro-domain of Xnr3 may be required for its activity. Since Xnr3 is a direct target of the maternal betacatenin/XTcf3 signaling pathway, it provides the link between the initial, maternally controlled, allocation of cell fate, and the morphogenetic movements of cells derived from the organizer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668633     DOI: 10.1242/dev.00434

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  26 in total

1.  E-selectin ligand-1 regulates growth plate homeostasis in mice by inhibiting the intracellular processing and secretion of mature TGF-beta.

Authors:  Tao Yang; Roberto Mendoza-Londono; Huifang Lu; Jianning Tao; Kaiyi Li; Bettina Keller; Ming Ming Jiang; Rina Shah; Yuqing Chen; Terry K Bertin; Feyza Engin; Branka Dabovic; Daniel B Rifkin; John Hicks; Milan Jamrich; Arthur L Beaudet; Brendan Lee
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

Review 2.  Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis.

Authors:  Nicholas J Kenney; Heather B Adkins; Michele Sanicola
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-04       Impact factor: 2.673

3.  Mustn1 is essential for craniofacial chondrogenesis during Xenopus development.

Authors:  Robert P Gersch; Arif Kirmizitas; Lidia Sobkow; Gina Sorrentino; Gerald H Thomsen; Michael Hadjiargyrou
Journal:  Gene Expr Patterns       Date:  2012-01-18       Impact factor: 1.224

4.  Regulation of Xenopus gastrulation by ErbB signaling.

Authors:  Shuyi Nie; Chenbei Chang
Journal:  Dev Biol       Date:  2006-11-10       Impact factor: 3.582

5.  Lrp6 is required for convergent extension during Xenopus gastrulation.

Authors:  Emilios Tahinci; Curtis A Thorne; Jeffrey L Franklin; Adrian Salic; Kelly M Christian; Laura A Lee; Robert J Coffey; Ethan Lee
Journal:  Development       Date:  2007-11       Impact factor: 6.868

6.  Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo.

Authors:  Vítezslav Bryja; Dietmar Gradl; Alexandra Schambony; Ernest Arenas; Gunnar Schulte
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-10       Impact factor: 11.205

Review 7.  Molecular basis of morphogenesis during vertebrate gastrulation.

Authors:  Yingqun Wang; Herbert Steinbeisser
Journal:  Cell Mol Life Sci       Date:  2009-04-04       Impact factor: 9.261

Review 8.  Controlling the Messenger: Regulated Translation of Maternal mRNAs in Xenopus laevis Development.

Authors:  Michael D Sheets; Catherine A Fox; Megan E Dowdle; Susanne Imboden Blaser; Andy Chung; Sookhee Park
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

9.  Lrig3 regulates neural crest formation in Xenopus by modulating Fgf and Wnt signaling pathways.

Authors:  Hui Zhao; Kosuke Tanegashima; Hyunju Ro; Igor B Dawid
Journal:  Development       Date:  2008-02-20       Impact factor: 6.868

10.  Modulation of the beta-catenin signaling pathway by the dishevelled-associated protein Hipk1.

Authors:  Sarah H Louie; Xiao Yong Yang; William H Conrad; Jeanot Muster; Stephane Angers; Randall T Moon; Benjamin N R Cheyette
Journal:  PLoS One       Date:  2009-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.